EcoDrugPlus

Ensembl ID : ENSMAMG00000024990
Gene Symbol: -
Cross references: -
249 Possible Orthologues:

Ensembl ID : ENSMAMG00000002153
Gene Symbol: -
Cross references: -
181 Possible Orthologues:

Ensembl ID : ENSMAMG00000022713
Gene Symbol: -
Cross references: -
228 Possible Orthologues:

Ensembl ID : ENSMAMG00000005878
Gene Symbol: -
Cross references: -
356 Possible Orthologues:

Ensembl ID : ENSMAMG00000003339
Gene Symbol: -
Cross references: -
189 Possible Orthologues:

Ensembl ID : ENSMAMG00000024449
Gene Symbol: -
Cross references: -
184 Possible Orthologues:

Ensembl ID : ENSMAMG00000004362
Gene Symbol: -
Cross references: -
184 Possible Orthologues:

Ensembl ID : ENSMAMG00000005981
Gene Symbol: -
Cross references: -
356 Possible Orthologues:

Ensembl ID : ENSMAMG00000024971
Gene Symbol: -
Cross references: -
389 Possible Orthologues:

Ensembl ID : ENSMAMG00000024950
Gene Symbol: -
Cross references: -
428 Possible Orthologues:

Ensembl ID : ENSMAMG00000026014
Gene Symbol: -
Cross references: -
428 Possible Orthologues:

Ensembl ID : ENSMAMG00000027441
Gene Symbol: -
Cross references: -
159 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).